Key facts
- Zeteo Tech’s last known valuation is $11.5M (Apr 2019).
- It has raised $4.5M across 1 recorded rounds; the latest was Seed Round ($2.0M) in Nov 2017.
- Notable investors include US National Science Foundation, United States Department of War, Gates Foundation, CARB-X, Anzu Partners — 9 tracked in total.
- Zeteo Tech has filed 2 Form Ds with the SEC, most recently Dec 2017 ($2.0M sold to 2 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Zeteo Tech
Funding rounds
1 roundsAbout Zeteo Tech
Operator of a biodefense and medical device company intended to develop a new class of fieldable biological mass spectrometers. The company's instruments identify airborne microbes, proteins, and lipids and can be used to screen for infectious diseases and other bio-threats, enabling healthcare professionals to automate and identify bio-threats in operational environments and lower the cost of ownership.
- Sector
- Healthcare
- HQ
- Sykesville, MD, United States
- Founded
- 2013
- Employees
- 21
- Website
- zeteotech.com/
- Ownership
- Privately Held (backing)
Zeteo Tech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zeteo Tech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zeteo Tech in its N-PORT filings yet. We sweep new filings monthly.